KR101397828B1 - 돼지 주조직적합항원 유래 폴리펩티드 및 이의 용도 - Google Patents

돼지 주조직적합항원 유래 폴리펩티드 및 이의 용도 Download PDF

Info

Publication number
KR101397828B1
KR101397828B1 KR1020120017314A KR20120017314A KR101397828B1 KR 101397828 B1 KR101397828 B1 KR 101397828B1 KR 1020120017314 A KR1020120017314 A KR 1020120017314A KR 20120017314 A KR20120017314 A KR 20120017314A KR 101397828 B1 KR101397828 B1 KR 101397828B1
Authority
KR
South Korea
Prior art keywords
cells
polypeptide
present
hla
peptide
Prior art date
Application number
KR1020120017314A
Other languages
English (en)
Korean (ko)
Other versions
KR20130095913A (ko
Inventor
이종길
박찬수
Original Assignee
충북대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 충북대학교 산학협력단 filed Critical 충북대학교 산학협력단
Priority to PCT/KR2012/001323 priority Critical patent/WO2013125738A1/fr
Priority to KR1020120017314A priority patent/KR101397828B1/ko
Publication of KR20130095913A publication Critical patent/KR20130095913A/ko
Application granted granted Critical
Publication of KR101397828B1 publication Critical patent/KR101397828B1/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020120017314A 2012-02-21 2012-02-21 돼지 주조직적합항원 유래 폴리펩티드 및 이의 용도 KR101397828B1 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/KR2012/001323 WO2013125738A1 (fr) 2012-02-21 2012-02-21 Polypeptides dérivés de l'antigène des leucocytes du porc et utilisation correspondante
KR1020120017314A KR101397828B1 (ko) 2012-02-21 2012-02-21 돼지 주조직적합항원 유래 폴리펩티드 및 이의 용도

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120017314A KR101397828B1 (ko) 2012-02-21 2012-02-21 돼지 주조직적합항원 유래 폴리펩티드 및 이의 용도

Related Child Applications (2)

Application Number Title Priority Date Filing Date
KR1020140040511A Division KR101397881B1 (ko) 2014-04-04 2014-04-04 돼지 주조직적합항원 유래 폴리펩티드 및 이의 용도
KR1020140040512A Division KR101397855B1 (ko) 2014-04-04 2014-04-04 돼지 주조직적합항원 유래 폴리펩티드 및 이의 용도

Publications (2)

Publication Number Publication Date
KR20130095913A KR20130095913A (ko) 2013-08-29
KR101397828B1 true KR101397828B1 (ko) 2014-05-20

Family

ID=49005907

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120017314A KR101397828B1 (ko) 2012-02-21 2012-02-21 돼지 주조직적합항원 유래 폴리펩티드 및 이의 용도

Country Status (2)

Country Link
KR (1) KR101397828B1 (fr)
WO (1) WO2013125738A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019006330A1 (fr) * 2017-06-30 2019-01-03 Indiana University Research And Technology Corporation Compositions et procédés de détection de la réactivité à des sla

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521448B1 (en) * 1997-08-19 2003-02-18 Diacrin, Inc. Porcine MHC class I genes and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Transplantation. 1999 Aug 27,68(4):473-9. *

Also Published As

Publication number Publication date
WO2013125738A1 (fr) 2013-08-29
KR20130095913A (ko) 2013-08-29

Similar Documents

Publication Publication Date Title
KR101808751B1 (ko) 폰 빌레브란트 인자(ｖＷＦ)-함유 제제, 및 그와 관련된 방법, 키트 및 용도
JP7071288B2 (ja) Ｔ細胞調節多量体ポリペプチド及びその使用方法
CN110325205B (zh) T细胞调节性多聚体多肽及其使用方法
CN111886241A (zh) 多聚体t细胞调节多肽及其使用方法
DK2633865T3 (en) USE OF INTERLEUKIN-22 IN THE TREATMENT OF VIRAL HEPATITIS
KR20170065026A (ko) 대사 장애 치료용으로 이용되는 조성물 및 방법
KR20110112299A (ko) 자가면역 및 염증성 장애의 치료에 사용하기 위한 가용성 폴리펩티드
JP2016523277A (ja) インターロイキン１５（ｉｌ−１５）アンタゴニスト並びに自己免疫疾患及び炎症性疾患の処置のためのその使用
KR20170084033A (ko) 질환 및 장애를 치료하기 위해 인터루킨-10을 사용하는 방법
AU2018231413B2 (en) Treatment of pruritus in horses
AU2016318929A1 (en) Treatment of insect bite hypersensitivity
WO2018217659A1 (fr) Méthodes d'utilisation de cd24 soluble pour traiter des événements indésirables liés au système immunitaire dans des thérapies anticancéreuses
US20220288177A1 (en) Production of mhc ii/cii complexes
CA2404340C (fr) Procedes permettant d'inhiber la destruction tissulaire induite par les lymphocytes t autoreactifs
KR101397828B1 (ko) 돼지 주조직적합항원 유래 폴리펩티드 및 이의 용도
JP2004500110A5 (fr)
KR102549520B1 (ko) 비염증성 식세포작용 유도 활성을 갖는 융합분자
KR101397855B1 (ko) 돼지 주조직적합항원 유래 폴리펩티드 및 이의 용도
KR101397881B1 (ko) 돼지 주조직적합항원 유래 폴리펩티드 및 이의 용도
CN110785430A (zh) 用于治疗纤维化和dna损伤介导的疾病的rage蛋白
JP7406620B2 (ja) 関節炎治療のためのｈｌａ－ｄｒ／ｃｉｉペプチド複合体
KR101625112B1 (ko) 아이케이 인자 및 아이케이 인자를 코딩하는 핵산의 약학적 용도
KR20150113558A (ko) 돼지 주조직적합항원 유래의 hla-a2-제한된 면역원성 펩티드 및 이의 용도
JP2004201547A (ja) マスト細胞の細胞死誘発剤
NZ616479A (en) Complement factor b analogs and their uses

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
A107 Divisional application of patent
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee